268 related articles for article (PubMed ID: 34103686)
1. CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma.
Wang S; Cao K; Liao Y; Zhang W; Zheng J; Li X; Huang M; Zhong Y; Hu X; Chen D; Wang Y
Oncogene; 2021 Jun; 40(25):4368-4383. PubMed ID: 34103686
[TBL] [Abstract][Full Text] [Related]
2. GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway.
Li J; Wang Q; Yang Y; Lei C; Yang F; Liang L; Chen C; Xia J; Wang K; Tang N
J Exp Clin Cancer Res; 2019 Oct; 38(1):438. PubMed ID: 31666108
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress indicated by elevated expression of Nrf2 and 8-OHdG promotes hepatocellular carcinoma progression.
Ma-On C; Sanpavat A; Whongsiri P; Suwannasin S; Hirankarn N; Tangkijvanich P; Boonla C
Med Oncol; 2017 Apr; 34(4):57. PubMed ID: 28281193
[TBL] [Abstract][Full Text] [Related]
4. SLC27A5 deficiency activates NRF2/TXNRD1 pathway by increased lipid peroxidation in HCC.
Gao Q; Zhang G; Zheng Y; Yang Y; Chen C; Xia J; Liang L; Lei C; Hu Y; Cai X; Zhang W; Tang H; Chen Y; Huang A; Wang K; Tang N
Cell Death Differ; 2020 Mar; 27(3):1086-1104. PubMed ID: 31367013
[TBL] [Abstract][Full Text] [Related]
5. CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT/CCND1 signaling.
Li J; Chen Y; Wang X; Wang C
J BUON; 2021; 26(3):882-888. PubMed ID: 34268949
[TBL] [Abstract][Full Text] [Related]
6. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract][Full Text] [Related]
7. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
Li K; Fan T; Shi Z; Jiang H
Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Nqo1 activity intercepts anoikis resistance and reduces metastatic potential of hepatocellular carcinoma.
Shimokawa M; Yoshizumi T; Itoh S; Iseda N; Sakata K; Yugawa K; Toshima T; Harada N; Ikegami T; Mori M
Cancer Sci; 2020 Apr; 111(4):1228-1240. PubMed ID: 31968140
[TBL] [Abstract][Full Text] [Related]
9. NRF2 SUMOylation promotes de novo serine synthesis and maintains HCC tumorigenesis.
Guo H; Xu J; Zheng Q; He J; Zhou W; Wang K; Huang X; Fan Q; Ma J; Cheng J; Mei W; Xing R; Cai R
Cancer Lett; 2019 Dec; 466():39-48. PubMed ID: 31546024
[TBL] [Abstract][Full Text] [Related]
10. S-1-propenylmercaptocysteine protects murine hepatocytes against oxidative stress via persulfidation of Keap1 and activation of Nrf2.
Tocmo R; Parkin K
Free Radic Biol Med; 2019 Nov; 143():164-175. PubMed ID: 31349040
[TBL] [Abstract][Full Text] [Related]
11. Activation of AKT pathway by Nrf2/PDGFA feedback loop contributes to HCC progression.
Liu D; Zhang Y; Wei Y; Liu G; Liu Y; Gao Q; Zou L; Zeng W; Zhang N
Oncotarget; 2016 Oct; 7(40):65389-65402. PubMed ID: 27588483
[TBL] [Abstract][Full Text] [Related]
12. Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway.
Qaisiya M; Coda Zabetta CD; Bellarosa C; Tiribelli C
Cell Signal; 2014 Mar; 26(3):512-20. PubMed ID: 24308969
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival.
Gorrini C; Baniasadi PS; Harris IS; Silvester J; Inoue S; Snow B; Joshi PA; Wakeham A; Molyneux SD; Martin B; Bouwman P; Cescon DW; Elia AJ; Winterton-Perks Z; Cruickshank J; Brenner D; Tseng A; Musgrave M; Berman HK; Khokha R; Jonkers J; Mak TW; Gauthier ML
J Exp Med; 2013 Jul; 210(8):1529-44. PubMed ID: 23857982
[TBL] [Abstract][Full Text] [Related]
14. Induction of Oxidative Stress Through Inhibition of Thioredoxin Reductase 1 Is an Effective Therapeutic Approach for Hepatocellular Carcinoma.
Lee D; Xu IM; Chiu DK; Leibold J; Tse AP; Bao MH; Yuen VW; Chan CY; Lai RK; Chin DW; Chan DF; Cheung TT; Chok SH; Wong CM; Lowe SW; Ng IO; Wong CC
Hepatology; 2019 Apr; 69(4):1768-1786. PubMed ID: 30561826
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in autophagy-induced hepatocellular carcinoma.
Zhou J; Zhang X; Tang H; Yu J; Zu X; Xie Z; Yang X; Hu J; Tan F; Li Q; Lei X
Clin Chim Acta; 2020 Jul; 506():1-8. PubMed ID: 32109431
[TBL] [Abstract][Full Text] [Related]
16. FGF19 Protects Hepatocellular Carcinoma Cells against Endoplasmic Reticulum Stress via Activation of FGFR4-GSK3β-Nrf2 Signaling.
Teng Y; Zhao H; Gao L; Zhang W; Shull AY; Shay C
Cancer Res; 2017 Nov; 77(22):6215-6225. PubMed ID: 28951455
[TBL] [Abstract][Full Text] [Related]
17. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
Tang M; Liao M; Ai X; He G
Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
[TBL] [Abstract][Full Text] [Related]
18. The protein kinase activity of fructokinase A specifies the antioxidant responses of tumor cells by phosphorylating p62.
Xu D; Li X; Shao F; Lv G; Lv H; Lee JH; Qian X; Wang Z; Xia Y; Du L; Zheng Y; Wang H; Lyu J; Lu Z
Sci Adv; 2019 Apr; 5(4):eaav4570. PubMed ID: 31032410
[TBL] [Abstract][Full Text] [Related]
19. ZNF32 protects against oxidative stress-induced apoptosis by modulating C1QBP transcription.
Li K; Gao B; Li J; Chen H; Li Y; Wei Y; Gong D; Gao J; Zhang J; Tan W; Wen T; Zhang L; Huang L; Xiang R; Lin P; Wei Y
Oncotarget; 2015 Nov; 6(35):38107-26. PubMed ID: 26497555
[TBL] [Abstract][Full Text] [Related]
20. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
